Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer

• 收藏
• 分享

专利权人:

发明人:

Katherine Lea Pogue-Geile,Soonmyung Paik

申请号：

US14286796

公开号：

US20140348821A1

申请日:

2014.05.23

申请国别(地区):

US

年份:

2014

代理人:

摘要：

Methods of testing to identify and to treat a subset of colon cancer patients exhibiting dMMR tumor tissue, who derive significant clinical benefit from the addition of bevacizumab to standard adjuvant chemotherapy. The presence of a V600E BRAF mutation is also of significance.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/